Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
29868 | 178 | 35.0 | 48% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
2020 | 2 | CELLULAR IMMUNOLOGY//IMMUNOLOGY//EPICUTANEOUS IMMUNIZATION | 5452 |
29868 | 1 | CONCOMITANT RESISTANCE//MURINE LEUKAEMIA//ESTUDIOS ONCOL | 178 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CONCOMITANT RESISTANCE | authKW | 617567 | 3% | 60% | 6 |
2 | MURINE LEUKAEMIA | authKW | 228729 | 1% | 67% | 2 |
3 | ESTUDIOS ONCOL | address | 175110 | 4% | 15% | 7 |
4 | ANTI TUMOR FACTORS | authKW | 171548 | 1% | 100% | 1 |
5 | ANTI TUMOUR FACTOR | authKW | 171548 | 1% | 100% | 1 |
6 | BALB C MAMMARY TUMOR CELL LINE | authKW | 171548 | 1% | 100% | 1 |
7 | C015 | address | 171548 | 1% | 100% | 1 |
8 | CANCER DEDIFFERENTIATION | authKW | 171548 | 1% | 100% | 1 |
9 | CONCOMITANT TUMOR IMMUNITY | authKW | 171548 | 1% | 100% | 1 |
10 | DORSAL REGION OF FOOT | authKW | 171548 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1440 | 47% | 0% | 83 |
2 | Medicine, General & Internal | 221 | 17% | 0% | 31 |
3 | Immunology | 171 | 16% | 0% | 29 |
4 | BIOLOGY, MISCELLANEOUS | 109 | 1% | 0% | 1 |
5 | Medicine, Research & Experimental | 81 | 9% | 0% | 16 |
6 | Mathematical & Computational Biology | 50 | 3% | 0% | 6 |
7 | CYTOLOGY & HISTOLOGY | 21 | 1% | 0% | 1 |
8 | Pathology | 10 | 3% | 0% | 5 |
9 | Cell Biology | 6 | 5% | 0% | 9 |
10 | Transplantation | 2 | 1% | 0% | 2 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ESTUDIOS ONCOL | 175110 | 4% | 15% | 7 |
2 | C015 | 171548 | 1% | 100% | 1 |
3 | ESTUDIO TRATAMIENTO ONCOL CETRO | 171548 | 1% | 100% | 1 |
4 | ESTUDIOS INMUNIDAD HUMORALIDEHUCONICET | 171548 | 1% | 100% | 1 |
5 | EXPT MED ILEX CONICET | 171548 | 1% | 100% | 1 |
6 | EXPTL MED INVEST HEMATOL | 171548 | 1% | 100% | 1 |
7 | HOP COCHINCNRS | 171548 | 1% | 100% | 1 |
8 | IMMUNODIAGNOST IMMUNOCORRECT | 171548 | 1% | 100% | 1 |
9 | NACL MED BUENOS AI | 171548 | 1% | 100% | 1 |
10 | NEW ANTITUMOR DRUGS | 171548 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MEDICINA-BUENOS AIRES | 42397 | 15% | 1% | 27 |
2 | THEORETICAL BIOLOGY AND MEDICAL MODELLING | 8533 | 3% | 1% | 5 |
3 | REVISTA DOYMA DE INMUNOLOGIA | 7796 | 1% | 5% | 1 |
4 | ARCHIV FUR GESCHWULSTFORSCHUNG | 4122 | 2% | 1% | 3 |
5 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 3192 | 5% | 0% | 9 |
6 | INVASION & METASTASIS | 1563 | 1% | 0% | 2 |
7 | CANCER RESEARCH | 1413 | 10% | 0% | 18 |
8 | ONCOLOGY RESEARCH | 1283 | 2% | 0% | 3 |
9 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | 1047 | 2% | 0% | 4 |
10 | INTERNATIONAL JOURNAL OF CANCER | 840 | 6% | 0% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CONCOMITANT RESISTANCE | 617567 | 3% | 60% | 6 | Search CONCOMITANT+RESISTANCE | Search CONCOMITANT+RESISTANCE |
2 | MURINE LEUKAEMIA | 228729 | 1% | 67% | 2 | Search MURINE+LEUKAEMIA | Search MURINE+LEUKAEMIA |
3 | ANTI TUMOR FACTORS | 171548 | 1% | 100% | 1 | Search ANTI+TUMOR+FACTORS | Search ANTI+TUMOR+FACTORS |
4 | ANTI TUMOUR FACTOR | 171548 | 1% | 100% | 1 | Search ANTI+TUMOUR+FACTOR | Search ANTI+TUMOUR+FACTOR |
5 | BALB C MAMMARY TUMOR CELL LINE | 171548 | 1% | 100% | 1 | Search BALB+C+MAMMARY+TUMOR+CELL+LINE | Search BALB+C+MAMMARY+TUMOR+CELL+LINE |
6 | CANCER DEDIFFERENTIATION | 171548 | 1% | 100% | 1 | Search CANCER+DEDIFFERENTIATION | Search CANCER+DEDIFFERENTIATION |
7 | CONCOMITANT TUMOR IMMUNITY | 171548 | 1% | 100% | 1 | Search CONCOMITANT+TUMOR+IMMUNITY | Search CONCOMITANT+TUMOR+IMMUNITY |
8 | DORSAL REGION OF FOOT | 171548 | 1% | 100% | 1 | Search DORSAL+REGION+OF+FOOT | Search DORSAL+REGION+OF+FOOT |
9 | DUCTAL PAPILLARY ADENOCARCINOMA | 171548 | 1% | 100% | 1 | Search DUCTAL+PAPILLARY+ADENOCARCINOMA | Search DUCTAL+PAPILLARY+ADENOCARCINOMA |
10 | EARLY TUMOR GROWTH | 171548 | 1% | 100% | 1 | Search EARLY+TUMOR+GROWTH | Search EARLY+TUMOR+GROWTH |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHIARELLA, P , BRUZZO, J , MEISS, RP , RUGGIERO, RA , (2012) CONCOMITANT TUMOR RESISTANCE.CANCER LETTERS. VOL. 324. ISSUE 2. P. 133-141 | 19 | 30% | 8 |
2 | RUGGIERO, RA , BRUZZO, J , CHIARELLA, P , DI GIANNI, P , ISTURIZ, MA , LINSKENS, S , SPEZIALE, N , MEISS, RP , BUSTUOABAD, OD , PASQUALINI, CD , (2011) TYROSINE ISOMERS MEDIATE THE CLASSICAL PHENOMENON OF CONCOMITANT TUMOR RESISTANCE.CANCER RESEARCH. VOL. 71. ISSUE 22. P. 7113-7124 | 14 | 37% | 9 |
3 | RUGGIERO, RA , BRUZZO, J , CHIARELLA, P , BUSTUOABAD, OD , MEISS, RP , PASQUALINI, CD , (2012) CONCOMITANT TUMOR RESISTANCE: THE ROLE OF TYROSINE ISOMERS IN THE MECHANISMS OF METASTASES CONTROL.CANCER RESEARCH. VOL. 72. ISSUE 5. P. 1043 -1050 | 16 | 30% | 14 |
4 | PREHN, RT , PREHN, LM , (1996) IMMUNOSTIMULATION OF CANCER VERSUS IMMUNOSURVEILLANCE.MEDICINA-BUENOS AIRES. VOL. 56. ISSUE . P. 65-73 | 12 | 63% | 12 |
5 | KORMOSH, NG , DAVIDOVA, TV , KOPYLTSOV, VN , SEREBRYAKOVA, MV , KABIEVA, AO , VOYUSHIN, KE , SITDIKOVA, SM , AMANDZHOLOV, BS , KISELEVSKII, MV , DONENKO, FV , (2015) CONFORMATIONAL CHANGES IN INTER-ALPHA-TRYPSIN INHIBITOR HEAVY CHAIN 4 ACTIVATE ITS TUMOR-SPECIFIC ACTIVITY IN MICE WITH B16 MELANOMA.MOLECULAR MEDICINE REPORTS. VOL. 12. ISSUE 3. P. 4483 -4493 | 7 | 58% | 0 |
6 | PREHN, RT , (2006) AN IMMUNE REACTION MAY BE NECESSARY FOR CANCER DEVELOPMENT.THEORETICAL BIOLOGY AND MEDICAL MODELLING. VOL. 3. ISSUE . P. - | 11 | 42% | 12 |
7 | MACHUCA, D , CHIARELLA, P , MONTAGNA, D , DRAN, G , MEISS, RP , RUGGIERO, RA , (2015) META-TYROSINE. A POWERFUL ANTI-METASTATIC FACTOR WITH UNDETECTABLE TOXIC-SIDE EFFECTS.MEDICINA-BUENOS AIRES. VOL. 75. ISSUE 1. P. 1 -5 | 6 | 60% | 2 |
8 | BONFIL, RD , BUSTUOABAD, OD , BINDA, MM , (1998) ANTIANGIOGENESIS AND APOPTOSIS AS MEDIATORS OF CONCOMITANT TUMOR RESISTANCE INDUCED BY CALU-6, A HUMAN LUNG CARCINOMA CELL LINE, IN NUDE MICE.ONCOLOGY RESEARCH. VOL. 10. ISSUE 1. P. 15-21 | 11 | 52% | 5 |
9 | NAORA, H , SENO, S , NAORA, H , (1998) REGULATION OF TUMOR GROWTH AS A 'TOTAL MASS' IN MICE: APOPTOSIS AS A MAJOR MECHANISM IN ALTERING GROWTH RATES OF SINGLE AND MULTIPLE COEXISTING TUMOR NODULES.PATHOLOGY INTERNATIONAL. VOL. 48. ISSUE 9. P. 730-738 | 9 | 56% | 4 |
10 | CHIARELLA, P , VULCANO, M , LABORDE, E , VERMEULEN, M , BRUZZO, J , REARTE, B , BUSTUOABAD, OD , RUGGIERO, RA , (2007) REVERSION OF THE IMMUNOLOGICAL ECLIPSE AND THERAPEUTIC VACCINATION AGAINST CANCER IN AN EXPERIMENTAL MODEL..MEDICINA-BUENOS AIRES. VOL. 67. ISSUE 1. P. 44-48 | 6 | 60% | 0 |
Classes with closest relation at Level 1 |